These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 22467511)
1. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008). Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511 [TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782 [TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
5. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea. Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241 [TBL] [Abstract][Full Text] [Related]
6. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792 [TBL] [Abstract][Full Text] [Related]
7. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402 [TBL] [Abstract][Full Text] [Related]
8. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Bernstein CN; Nugent Z; Blanchard JF Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180 [TBL] [Abstract][Full Text] [Related]
9. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308 [TBL] [Abstract][Full Text] [Related]
10. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population? Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159 [TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504 [TBL] [Abstract][Full Text] [Related]
12. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008 [TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer prognosis among patients with inflammatory bowel disease. Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697 [TBL] [Abstract][Full Text] [Related]
14. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study. Bogach J; Pond G; Eskicioglu C; Seow H Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449 [TBL] [Abstract][Full Text] [Related]
15. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? Dyson JK; Rutter MD World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036 [TBL] [Abstract][Full Text] [Related]
17. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study. Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788 [No Abstract] [Full Text] [Related]
18. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease. Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893 [TBL] [Abstract][Full Text] [Related]
19. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F; Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909 [TBL] [Abstract][Full Text] [Related]
20. Cancer risk in patients with inflammatory bowel disease: a population-based study. Bernstein CN; Blanchard JF; Kliewer E; Wajda A Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]